Search

Author/Creator Li, Hanbin

1. Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study. (19th December 2018)

Authors:
Kirschbrown, Whitney P.; Wynne, Chris; Kågedal, Matts; Wada, Russ; Li, Hanbin; Wang, Bei; Nijem, Ihsan; Badovinac Crnjevic, Tanja; Gasser, Helena; Heeson, Sarah; Eng‐Wong, Jennifer; Garg, Amit
Journal:
Journal of clinical pharmacology
Issue:
Volume 59:Number 5(2019)
Page Start:
702
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Heteroatomic interface engineering of an octahedron VSe2–ZrO2/C/MXene composite derived from a MXene-MOF hybrid as a superior-performance anode for lithium-ion batteries. Issue 6 (18th January 2023)

Authors:
Li, Hanbin; Li, Jinliang; Ma, Liang; Zhang, Xinlu; Li, Junfeng; Li, Jiabao; Lu, Ting; Pan, Likun
Journal:
Journal of materials chemistry
Issue:
Volume 11:Issue 6(2023)
Page Start:
2836
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗